Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Olfactory receptor family 2 subfamily Z member 1 (OR2Z1) is a G protein-coupled receptor (GPCR) in humans that participates in the detection of odorant molecules in the nose, initiating the neuronal responses that underlie the perception of smell[1][5][8]. Like other olfactory receptors, OR2Z1 is a member of a large gene family characterized by a seven-transmembrane domain, sharing structural features with other neurotransmitter and hormone receptors[1][5][8]. These receptors are typically encoded by single-exon genes. While expression of OR2Z1 has been confirmed in the olfactory epithelium, it generally does not serve as a therapeutic drug target, and there are no established drug interactions or clinical applications at this time[3][5][8]. Some studies have linked olfactory receptor gene variations to non-olfactory disease processes, but no prominent role for OR2Z1 has been established in human disease[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Olfactory receptor family 2 subfamily Z member 1 (OR2Z1).